Please assess the completion status of the following clinical trial:

Trial Title: Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic, radiographically proven degenerative joint disease in the hip or knee~Exclusion Criteria:~* recent injection in the hip or knee within the previous 3 months~* history of traumatic osteoarthritis or ligamentous reconstruction~* chronic narcotic use~* history of inflammatory or neuropathic arthropathy~* pregnant and/or nursing women~* allergy or strong reaction to study medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Ketorolac Intraarticular Hip Injection (Type: EXPERIMENTAL): Patients will receive an intraarticular hip injection with ketorolac.
- Triamcinolone Intraarticular Hip Injection (Type: ACTIVE_COMPARATOR): Patients will receive an intraarticular hip injection with triamcinolone.
- Ketorolac Intraarticular Knee Injection (Type: EXPERIMENTAL): Patients will receive an intraarticular knee injection with ketorolac.
- Triamcinolone Intraarticular Knee Injection (Type: ACTIVE_COMPARATOR): Patients will receive an intraarticular knee injection with triamcinolone.

Based on this trial design, predict the completion outcome and termination type (if applicable).